Current Liabilities
Accounts Payable
Merck & Co. Accounts Payable decreased by 12.3% to $3.86B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.1%, from $3.78B to $3.86B. Over 5 years (FY 2020 to FY 2025), Accounts Payable shows relatively stable performance with a 0.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026May 4, 2026
How to read this metric
An increase can signal improved cash management or extended payment terms, whereas a decrease might indicate faster payments to suppliers or reduced purchasing activity.
Detailed definition
This represents the outstanding obligations owed to suppliers and vendors for goods and services received but not yet pa...
Peer comparison
Large, creditworthy corporations often leverage their scale to negotiate longer payment terms, resulting in higher accounts payable relative to smaller peers.
Metric ID:
accounts_payableHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.90B | $3.37B | $4.61B | $3.72B | $3.48B | $3.37B | $4.26B | $3.68B | $3.44B | $3.51B | $3.92B | $3.51B | $3.52B | $3.59B | $4.08B | $3.78B | $3.89B | $4.15B | $4.40B | $3.86B |
| QoQ Change | — | -13.6% | +36.9% | -19.4% | -6.3% | -3.2% | +26.5% | -13.7% | -6.5% | +1.9% | +11.8% | -10.4% | +0.1% | +1.9% | +13.7% | -7.2% | +2.9% | +6.6% | +6.2% | -12.3% |
| YoY Change | — | — | — | — | -10.6% | +0.1% | -7.5% | -0.9% | -1.1% | +4.1% | -8.0% | -4.5% | +2.2% | +2.2% | +4.0% | +7.7% | +10.6% | +15.6% | +8.0% | +2.1% |
Range$3.37B – $4.61B
CAGR-0.2%
Avg YoY Growth+1.5%
Median YoY Growth+2.1%
Accounts Payable at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s accounts payable?
- Merck & Co. (MRK) reported accounts payable of $3.86B in Q1 2026.
- How has Merck & Co.'s accounts payable changed year-over-year?
- Merck & Co.'s accounts payable increased by 2.1% year-over-year, from $3.78B to $3.86B.
- What is the long-term trend for Merck & Co.'s accounts payable?
- Over 5 years (2020 to 2025), Merck & Co.'s accounts payable has grown at a 0.4% compound annual growth rate (CAGR), from $4.33B to $4.40B.
- What does accounts payable mean?
- Money the company owes to its suppliers for goods or services already delivered.